Laura L Hammitt

Summary

Publications

  1. doi request reprint Repeat revaccination with 23-valent pneumococcal polysaccharide vaccine among adults aged 55-74 years living in Alaska: no evidence of hyporesponsiveness
    Laura L Hammitt
    Arctic Investigations Program, Centers for Disease Control and Prevention CDC, 4055 Tudor Centre Dr, Anchorage, AK 99508, USA
    Vaccine 29:2287-95. 2011
  2. pmc Added value of an oropharyngeal swab in detection of viruses in children hospitalized with lower respiratory tract infection
    Laura L Hammitt
    KEMRI Wellcome Trust Research Programme, Kilifi, Kenya
    J Clin Microbiol 49:2318-20. 2011
  3. ncbi request reprint Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage
    Rosalyn J Singleton
    Arctic Investigations Program, National Center for Preparedness Detection and Control of Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, Alaska, USA
    JAMA 297:1784-92. 2007
  4. pmc Influenza surveillance among children with pneumonia admitted to a district hospital in coastal Kenya, 2007-2010
    Clayton O Onyango
    KEMRI Wellcome Trust Research Programme, Kilifi District Hospital, Kilifi, Kenya
    J Infect Dis 206:S61-7. 2012
  5. doi request reprint Persistence of antibody to hepatitis A virus 10 years after vaccination among children and adults
    Laura L Hammitt
    Arctic Investigations Program, National Center for Preparedness, Detection and Control of Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    J Infect Dis 198:1776-82. 2008
  6. ncbi request reprint Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease
    Laura L Hammitt
    Arctic Investigations Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, Alaska 99508, USA
    J Infect Dis 193:1487-94. 2006
  7. ncbi request reprint Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years
    Laura L Hammitt
    Arctic Investigations Program, Centers for Disease Control and Prevention, Anchorage, AK, USA
    Vaccine 25:6958-64. 2007
  8. pmc Immunogenicity, impact on carriage and reactogenicity of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine in Kenyan children aged 1-4 years: a randomized controlled trial
    Laura L Hammitt
    KEMRI Wellcome Trust Research Programme, Centre for Geographic Medicine Coast, Kilifi, Kenya Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America
    PLoS ONE 9:e85459. 2014
  9. pmc Treatment failure among Kenyan children with severe pneumonia--a cohort study
    Clare Webb
    Kenya Medical Research Institute KEMRI, Centre for Geographic Medicine Research, Kilifi, Kenya
    Pediatr Infect Dis J 31:e152-7. 2012

Collaborators

Detail Information

Publications9

  1. doi request reprint Repeat revaccination with 23-valent pneumococcal polysaccharide vaccine among adults aged 55-74 years living in Alaska: no evidence of hyporesponsiveness
    Laura L Hammitt
    Arctic Investigations Program, Centers for Disease Control and Prevention CDC, 4055 Tudor Centre Dr, Anchorage, AK 99508, USA
    Vaccine 29:2287-95. 2011
    ..Antibody concentrations decline following vaccination. We evaluated the immunogenicity and reactogenicity of revaccination and repeat revaccination...
  2. pmc Added value of an oropharyngeal swab in detection of viruses in children hospitalized with lower respiratory tract infection
    Laura L Hammitt
    KEMRI Wellcome Trust Research Programme, Kilifi, Kenya
    J Clin Microbiol 49:2318-20. 2011
    ..Oropharyngeal swabs increased the number of viral infections detected by 15%, compared to collection of a nasopharyngeal swab alone. This advantage was most pronounced for detection of influenza, parainfluenza, and adenovirus...
  3. ncbi request reprint Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage
    Rosalyn J Singleton
    Arctic Investigations Program, National Center for Preparedness Detection and Control of Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, Alaska, USA
    JAMA 297:1784-92. 2007
    ....
  4. pmc Influenza surveillance among children with pneumonia admitted to a district hospital in coastal Kenya, 2007-2010
    Clayton O Onyango
    KEMRI Wellcome Trust Research Programme, Kilifi District Hospital, Kilifi, Kenya
    J Infect Dis 206:S61-7. 2012
    ..Influenza data gaps in sub-Saharan Africa include incidence, case fatality, seasonal patterns, and associations with prevalent disorders...
  5. doi request reprint Persistence of antibody to hepatitis A virus 10 years after vaccination among children and adults
    Laura L Hammitt
    Arctic Investigations Program, National Center for Preparedness, Detection and Control of Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    J Infect Dis 198:1776-82. 2008
    ..Hepatitis A vaccination is effective in preventing disease. However, the duration of protection after vaccination is unknown...
  6. ncbi request reprint Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease
    Laura L Hammitt
    Arctic Investigations Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, Alaska 99508, USA
    J Infect Dis 193:1487-94. 2006
    ..Vaccine use has also indirectly decreased the rate of invasive disease in adults, presumably through decreased transmission of pneumococci from vaccinated children to adults...
  7. ncbi request reprint Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years
    Laura L Hammitt
    Arctic Investigations Program, Centers for Disease Control and Prevention, Anchorage, AK, USA
    Vaccine 25:6958-64. 2007
    ..These children had protective anti-HBs concentrations when tested after receiving a three-dose series of 2.5 microg recombinant hepatitis B vaccine starting at birth...
  8. pmc Immunogenicity, impact on carriage and reactogenicity of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine in Kenyan children aged 1-4 years: a randomized controlled trial
    Laura L Hammitt
    KEMRI Wellcome Trust Research Programme, Centre for Geographic Medicine Coast, Kilifi, Kenya Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America
    PLoS ONE 9:e85459. 2014
    ..The impact on carriage and optimal schedule for primary vaccination of older children with 10-valent pneumococcal non-typeable Haemophilus influenzae protein-D conjugate vaccine (PHiD-CV) are unknown...
  9. pmc Treatment failure among Kenyan children with severe pneumonia--a cohort study
    Clare Webb
    Kenya Medical Research Institute KEMRI, Centre for Geographic Medicine Research, Kilifi, Kenya
    Pediatr Infect Dis J 31:e152-7. 2012
    ..Pneumonia is the leading cause of childhood mortality worldwide. The World Health Organization recommends presumptive treatment based on clinical syndromes. Recent studies raise concerns over the frequency of treatment failure in Africa...